Tropical Biomarine Systems Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-06-2024
- Paid Up Capital ₹ 0.95 M
as on 24-06-2024
- Company Age 24 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.60 M
as on 24-06-2024
- Revenue 38.39%
(FY 2021)
- Profit 3.67%
(FY 2021)
- Ebitda 89.97%
(FY 2021)
- Net Worth 5.87%
(FY 2021)
- Total Assets 3.48%
(FY 2021)
About Tropical Biomarine Systems
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹6.60 M.
Rajesh Khanna and Subbarayan Dhaneshwar serve as directors at the Company.
- CIN/LLPIN
U05004TN2000PTC046235
- Company No.
046235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tropical Biomarine Systems Private Limited offer?
Tropical Biomarine Systems Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Bird Food, Poultry & Animal Food, Fish Foods.
Who are the key members and board of directors at Tropical Biomarine Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Khanna  | Additional Director | 09-Jan-2024 | Current |
| Subbarayan Dhaneshwar | Director | 04-Dec-2000 | Current |
Financial Performance of Tropical Biomarine Systems.
Tropical Biomarine Systems Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 38.39% increase. The company also saw a slight improvement in profitability, with a 3.67% increase in profit. The company's net worth moved up by a moderate rise of 5.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tropical Biomarine Systems?
In 2021, Tropical Biomarine Systems had a promoter holding of 69.43% and a public holding of 30.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2002 | ₹6.60 M | Open |
How Many Employees Work at Tropical Biomarine Systems?
Unlock and access historical data on people associated with Tropical Biomarine Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tropical Biomarine Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tropical Biomarine Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
